Effect of silymarin therapy on liver aminotransferase in non-alcoholic fatty liver disease
Medical Forum Monthly. 2015; 26 (12): 46-49
in English
| IMEMR
| ID: emr-184729
ABSTRACT
Objective:
The present study evaluated the effects of silymarin on blood glucose, blood lipids and liver amino-transferase [AST and ALT] in Non-alcoholic fatty liver disease [NAFLD]
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Med. Forum Mon.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS